Skip to content
healthcare.dev

Ibrance

NDC 0069-0284, palbociclib, tablet, film coated, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-0284
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212436
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0284 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALBOCICLIB75 mg/1

Pharmacologic classes

Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0069-0284-03000690284033 DOSE PACK in 1 CARTON (0069-0284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (0069-0284-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fecbdd7d-b729-41b5-9872-231b8fe104ce

Use it

Look up 0069-0284 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0284 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-0284. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.